Issuance of Stock Acquisition Rights to Directors
First written in FY2018-Q2. 15 of 16 entries say "Advanced", first in FY2018. Latest entry: 2026-07-16.
- FY2026AdvancedAnnual report
「43,500 shares were allocated to the exercise of stock options structured as stock-based compensation. Resolution of the Board of Directors dated 27 June 2025. Eligible recipients and number of recipients: the Company's directors, excluding outside directors, 6. Number of stock acquisition rights: 60. Class, details and number of underlying shares: common shares, 30,000.」
For stock options for directors, 43,500 shares were allocated to exercise, while rights equivalent to 30,000 shares were granted to 6 directors under the 2025 resolution. - FY2026-H1AdvancedAnnual report
「Resolution of the Board of Directors dated 27 June 2025. Eligible recipients and number of recipients: the Company's directors, excluding outside directors, 6. Number of stock acquisition rights: 60. Class, details and number of underlying shares: common shares, 30,000. Amount payable upon exercise: ¥1 per share. Exercise period: from 15 July 2025 to 14 July 2040.」
Stock acquisition rights were issued to 6 directors, comprising 60 rights for 30,000 underlying shares, with an exercise price of ¥1 per share and an exercise period from 15 July 2025 to 14 July 2040. - FY2025AdvancedAnnual report
「The number decreased by 41,500 shares through the exercise of stock options structured as stock-based compensation and by 0 thousand shares through the disposal of odd-lot shares.」
The number of shares underlying stock options for directors decreased by 41,500 through the allocation of shares to exercise. - FY2025-H1AdvancedAnnual report
「Resolution of the Board of Directors dated 27 June 2024. Eligible recipients and number of recipients: the Company's directors, excluding outside directors, 6. Number of stock acquisition rights: 48. Class, details and number of underlying shares: common shares, 24,000. Amount payable upon exercise: ¥1 per share. Exercise period: from 17 July 2024 to 16 July 2039.」
Stock acquisition rights were issued to 6 directors, comprising 48 rights for 24,000 underlying shares, with an exercise price of ¥1 per share and an exercise period from 17 July 2024 to 16 July 2039. - FY2024AdvancedAnnual report
「Resolution of the Board of Directors dated 29 June 2023. Eligible recipients and number of recipients: the Company's directors, excluding outside directors, 6. Number of stock acquisition rights: 64. Class, details and number of underlying shares: common shares, 32,000. 73,000 shares were allocated to the exercise of stock options structured as stock-based compensation.」
Stock acquisition rights equivalent to 32,000 shares were granted to 6 directors, and during the fiscal year, 73,000 shares under existing stock options were allocated to exercise. - FY2023AdvancedAnnual report
「Resolution of the Board of Directors dated 29 June 2023. Eligible recipients and number of recipients: the Company's directors, excluding outside directors, 6. Number of stock acquisition rights: 64. Class, details and number of underlying shares: common shares, 32,000.」
On 29 June 2023, stock options were issued to 6 directors, comprising 64 rights for 32,000 underlying shares, with an exercise price of ¥1 per share. - FY2023-Q2AdvancedAnnual report
「Resolution of the Board of Directors dated 29 June 2022. Eligible recipients and number of recipients: the Company's directors, excluding outside directors, 6. Number of stock acquisition rights: 105. Class, details and number of underlying shares: common shares, 52,500. Amount payable upon exercise: ¥1 per share. Exercise period: from 16 July 2022 to 15 July 2037.」
Stock acquisition rights were issued to 6 directors, comprising 105 rights for 52,500 underlying shares, with an exercise price of ¥1 per share and an exercise period from 16 July 2022 to 15 July 2037. - FY2022AdvancedAnnual report
「The number decreased by 133,500 shares through the exercise of stock options structured as stock-based compensation and by 0 thousand shares through the disposal of odd-lot shares.」
133,500 shares were allocated to the exercise of stock options for directors. - FY2021-Q2AdvancedAnnual report
「Board resolution dated 26 June 2020; categories and number of eligible recipients (people): directors of the company, excluding outside directors, 9; number of stock acquisition rights*: 221; class, details and number of underlying shares*: common shares, 110,500; payment amount upon exercise of stock acquisition rights*: ¥1 per share; exercise period*: from 15 July 2020 to 14 July 2035」
Stock acquisition rights were issued to 9 directors, comprising 221 rights for 110,500 underlying shares, with an exercise price of ¥1 per share and an exercise period from 15 July 2020 to 14 July 2035. - FY2020-Q2AdvancedAnnual report
「Board resolution dated 26 June 2019; categories and number of eligible recipients (people): directors of the company, excluding outside directors, 9; number of stock acquisition rights*: 137; class, details and number of underlying shares*: common shares, 68,500; payment amount upon exercise of stock acquisition rights*: ¥1 per share; exercise period*: from 13 July 2019 to 12 July 2034」
Stock acquisition rights were issued to 9 directors, representing 68,500 underlying shares, at an exercise price of ¥1 per share, with an exercise period from 13 July 2019 to 12 July 2034. - FY2019AdvancedAnnual report
「Other (exercise of stock acquisition rights) 99,500 49」
The disclosure states that 99,500 shares were allocated for the exercise of stock options for directors during the year, at a disposal value of ¥49 million. - FY2019-Q2AdvancedAnnual report
「Board resolution dated 27 June 2018; categories and number of eligible recipients (people): directors of the company, excluding outside directors, 9; number of stock acquisition rights: 130; class, details and number of underlying shares: common shares, 65,000; payment amount upon exercise of stock acquisition rights: ¥1 per share; exercise period: from 14 July 2018 to 13 July 2033」
Stock acquisition rights were issued to 9 directors, representing 65,000 underlying shares, at an exercise price of ¥1 per share, with an exercise period from 14 July 2018 to 13 July 2033. - FY2018AdvancedAnnual report
「The number of shares decreased by 120 thousand through allocation for the exercise of stock options granted as share-based compensation and by 0 thousand through the disposal of less-than-one-unit shares.」
During the year, 120 thousand shares underlying previously issued stock options for directors decreased through allocation for the exercise of the rights. - FY2018-Q2First statedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
Based on the resolution of 28 June 2017, 71 stock acquisition rights covering 35,500 shares were issued at an exercise price of ¥1 per share. The exercise period runs from 15 July 2017 to 14 July 2032.